Profit taking weighs down Proteostasis Therapeutics

Profit taking sent shares of Proteostasis Therapeutics Inc. (Nasdaq: PTI) tumbling $1.43 to close at $3.20.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.